Meyer Handelman Company’s CVS Health CVS Stock Holding History

Meyer Handelman Company’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.13M	Sell	43,572 -4,500	-9%	-$347K	0.1%	111
2025 Q4	$3.81M	Sell	48,072 -7,346	-13%	-$579K	0.12%	106
2025 Q3	$4.18M	Sell	55,418 -4,050	-7%	-$278K	0.13%	106
2025 Q2	$4.1M	Sell	59,468 -22,493	-27%	-$1.47M	0.14%	106
2025 Q1	$5.55M	Sell	81,961 -30,850	-27%	-$1.85M	0.19%	100
2024 Q4	$5.06M	Sell	112,811 -9,103	-7%	-$511K	0.18%	102
2024 Q3	$7.67M	Sell	121,914 -8,601	-7%	-$502K	0.26%	90
2024 Q2	$7.71M	Sell	130,515 -475	-0.4%	-$29.7K	0.27%	86
2024 Q1	$10.4M	Buy	130,990 +7,656	+6%	+$585K	0.37%	73
2023 Q4	$9.74M	Hold	123,334	–	–	0.38%	74
2023 Q3	$8.61M	Sell	123,334 -1,450	-1%	-$103K	0.35%	78
2023 Q2	$8.63M	Sell	124,784 -70	-0.1%	-$4.98K	0.35%	79
2023 Q1	$9.28M	Hold	124,854	–	–	0.39%	75
2022 Q4	$11.6M	Hold	124,854	–	–	0.49%	64
2022 Q3	$11.9M	Sell	124,854 -75	-0.1%	-$7.42K	0.55%	56
2022 Q2	$11.6M	Hold	124,929	–	–	0.5%	59
2022 Q1	$12.6M	Sell	124,929 -2,100	-2%	-$221K	0.48%	63
2021 Q4	$13.1M	Buy	127,029 +2,304	+2%	+$213K	0.49%	62
2021 Q3	$10.6M	Hold	124,725	–	–	0.43%	70
2021 Q2	$10.4M	Sell	124,725 -7,100	-5%	-$581K	0.41%	72
2021 Q1	$9.92M	Buy	131,825 +5,349	+4%	+$390K	0.41%	71
2020 Q4	$8.64M	Buy	126,476 +6,833	+6%	+$444K	0.39%	71
2020 Q3	$6.99M	Sell	119,643 -3,000	-2%	-$187K	0.36%	71
2020 Q2	$7.97M	Hold	122,643	–	–	0.42%	67
2020 Q1	$7.28M	Sell	122,643 -2	-0%	-$134	0.45%	65
2019 Q4	$9.11M	Hold	122,645	–	–	0.44%	66
2019 Q3	$7.74M	Buy	122,645 +1,000	+0.8%	+$59.3K	0.39%	71
2019 Q2	$6.63M	Buy	121,645 +10,492	+9%	+$565K	0.34%	73
2019 Q1	$5.97M	Buy	111,153 +100	+0.1%	+$6.17K	0.31%	76
2018 Q4	$7.28M	Buy	111,053 +670	+0.6%	+$50K	0.41%	67
2018 Q3	$8.69M	Buy	110,383 +1,800	+2%	+$129K	0.42%	67
2018 Q2	$6.99M	Hold	108,583	–	–	0.36%	76
2018 Q1	$6.75M	Buy	108,583 +2,750	+3%	+$197K	0.34%	80
2017 Q4	$7.67M	Sell	105,833 -61,000	-37%	-$4.43M	0.37%	73
2017 Q3	$13.6M	Buy	166,833 +6,600	+4%	+$522K	0.62%	52
2017 Q2	$12.9M	Sell	160,233 -4,000	-2%	-$316K	0.54%	62
2017 Q1	$12.9M	Buy	164,233 +125	+0.1%	+$9.98K	0.55%	61
2016 Q4	$12.9M	Hold	164,108	–	–	0.57%	60
2016 Q3	$14.6M	Buy	164,108 +175	+0.1%	+$16.5K	0.66%	55
2016 Q2	$15.7M	Sell	163,933 -1,919	-1%	-$191K	0.7%	52
2016 Q1	$17.2M	Hold	165,852	–	–	0.8%	45
2015 Q4	$16.2M	Buy	165,852 +11,000	+7%	+$1.08M	0.77%	45
2015 Q3	$14.9M	Sell	154,852 -100	-0.1%	-$10.5K	0.76%	46
2015 Q2	$16.3M	Buy	154,952 +1,019	+0.7%	+$104K	0.74%	48
2015 Q1	$15.9M	Sell	153,933 -300	-0.2%	-$30.4K	0.72%	50
2014 Q4	$14.9M	Hold	154,233	–	–	0.67%	54
2014 Q3	$12.3M	Hold	154,233	–	–	0.57%	60
2014 Q2	$11.6M	Sell	154,233 -1,013	-0.7%	-$76.6K	0.54%	63
2014 Q1	$11.6M	Sell	155,246 -1,200	-0.8%	-$84.8K	0.56%	61
2013 Q4	$11.2M	Hold	156,446	–	–	0.54%	62
2013 Q3	$8.88M	Hold	156,446	–	–	0.47%	68
2013 Q2	$8.95M	Buy	+156,446	New	+$9.06M	0.49%	66

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Meyer Handelman Company's CVS Position: Q1 2026 in Review

Meyer Handelman Company reduced its CVS Health (CVS) stake by 9.4% in Q1 2026, selling an estimated $347K and leaving 43,572 shares worth $3.13M. The position accounts for 0.1% of the portfolio, ranked #111.

Meyer Handelman Company first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.2M in Q1 2016. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Meyer Handelman Company held 43,572 shares of CVS Health worth $3.13M as of Q1 2026.
Meyer Handelman Company sold 4,500 CVS Health shares in Q1 2026, an estimated $347K.
CVS Health made up 0.1% of Meyer Handelman Company's portfolio in Q1 2026, its #111 holding.
Meyer Handelman Company first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
Meyer Handelman Company's CVS Health position peaked at $17.2M in Q1 2016.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Meyer Handelman Company's 13F filing for Q1 2026, filed 20 Apr 2026.